Drug Trial Radar · NCT07285798
A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism Spectrum Disorder
Last checked: Nov 19, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
176
Planned (sponsor's estimate)
Start
Oct 6, 2026
Primary completion
Aug 6, 2029
Study completion Aug 6, 2029
Sponsor
- Lead sponsor
- Bristol-Myers SquibbBristol Myers Squibb (BMY)
- Sponsor type
- Industry
- First posted
- Dec 16, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 5 years, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess KarXT + KarX-EC for the treatment of irritability associated with autism in children and adolescents.
Conditions
- Irritability Associated With Autism Spectrum Disorder
Interventions
KarXTDrug
Specified dose on specified days
KarX-ECDrug
Specified dose on specified days
KarXT + KarX-EC Matching PlaceboDrug
Specified dose on specified days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in the Aberrant Behavior Checklist Irritability (ABC-I) Score at Week 8Time frame: Week 8
Locations
67 sites in 10 countries. Site status is shown where the registry gives one.
Local Institution - 0062
Phoenix, Arizona · Not yet recruiting
Cortica - Glendale
Glendale, California · Recruiting
Local Institution - 0117
Los Angeles, California · Not yet recruiting
Local Institution - 0126
Orange, California · Not yet recruiting
Local Institution - 0132
San Diego, California · Not yet recruiting
Local Institution - 0115
San Juan Capistrano, California · Not yet recruiting
Cortica - Marin
San Rafael, California · Recruiting
Local Institution - 0130
New Haven, Connecticut · Not yet recruiting
Local Institution - 0048
Gainesville, Florida · Not yet recruiting
Local Institution - 0080
Orlando, Florida · Not yet recruiting
Local Institution - 0072
Decatur, Georgia · Not yet recruiting
EmVenio Research - Chicago
Chicago, Illinois · Recruiting
Local Institution - 0026
Chicago, Illinois · Withdrawn
Local Institution - 0051
Lexington, Massachusetts · Not yet recruiting
Local Institution - 0140
Bloomfield Hills, Michigan · Not yet recruiting
Local Institution - 0016
Columbia, Missouri · Not yet recruiting
Local Institution - 0036
Saint Charles, Missouri · Not yet recruiting
Local Institution - 0046
Lincoln, Nebraska · Not yet recruiting
Local Institution - 0114
Neptune City, New Jersey · Not yet recruiting
Local Institution - 0038
Staten Island, New York · Not yet recruiting
Local Institution - 0052
Cincinnati, Ohio · Not yet recruiting
Local Institution - 0003
Pittsburgh, Pennsylvania · Not yet recruiting
Local Institution - 0125
Spring, Texas · Not yet recruiting
Local Institution - 0009
Orem, Utah · Not yet recruiting
Local Institution - 0019
Everett, Washington · Not yet recruiting
Local Institution - 0088
Bordeaux, France · Withdrawn
Local Institution - 0102
Bron, France · Not yet recruiting
Local Institution - 0089
Paris, France · Not yet recruiting
Local Institution - 0103
Gdansk, Germany · Not yet recruiting
Local Institution - 0111
Budapest, Hungary · Withdrawn
Local Institution - 0127
Budapest, Hungary · Not yet recruiting
Local Institution - 0110
Szeged, Hungary · Not yet recruiting
Local Institution - 0099
Nagpur, India · Not yet recruiting
Local Institution - 0137
New Delhi, India · Not yet recruiting
Local Institution - 0096
Kozhikode, Kerala, India · Not yet recruiting
Local Institution - 0136
Nashik, Maharashtra, India · Not yet recruiting
Local Institution - 0139
Pune, Maharashtra, India · Not yet recruiting
Local Institution - 0101
Sakri, Maharashtra, India · Not yet recruiting
Local Institution - 0138
Kanpur, Uttar Pradesh, India · Not yet recruiting
Local Institution - 0093
Yokohama, Kanagawa, Japan · Not yet recruiting
Showing 40 of 67 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.